Abzena, an end-to-end CDMO for biologics and bioconjugates, has launched AbZelect and AbZelectPRO cell line development (CLD) platforms to accelerate cell lie production for manufacturing antibodies and recombinant proteins.
Global CDMO Vetter (Germany) has joined the Science Based Targets Initiative (SBTi) membership group, which aims to achieve climate neutrality by 2050, thus representing the strictest climate protection targets for companies worldwide. Click to read more.
Tola Olorunnisola is currently senior vice president, clinical services & strategy at Avantor and along with her team is working on delivering digital innovations in the lab.